The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization.
Galatea KallergiVasileia TsintariStelios SfakianakisEkaterini BeiEleni LagoudakiAnastasios KoutsopoulosNefeli ZacharopoulouSaad AlkahtaniSaud AlarifiChristos StournarasMichalis ZervakisVassilis GeorgouliasPublished in: Breast cancer research : BCR (2019)
CXCR4, JUNB, and TYROBP were overexpressed in CTCs, but only the expression of JUNB was associated with poor prognosis, providing a new biomarker and a potential therapeutic target for the elimination of CTCs.